|By RealWire News Distribution||
|March 21, 2014 11:11 PM EDT||
GSTS Pathology have implemented Ascribe's Business Intelligence (BI) solution to advance the processing, analysis and reporting of business data through the creation of a minimum data set that integrates activity data across all sites and platforms and allows for a single view of the activity within the business.
Working in close partnership GSTS Pathology and Ascribe have built a Microsoft SQL Server 2012 platform to leverage insight from millions of historic and current data records which can now be easily accessed, analysed and reported upon, creating greater capacity for trend, variance and predictive analysis.
Using Excel 2013 to connect to the BI reporting solution gives users a familiar interface on which to simply manage their views of activity. Provision of standard, intuitive templates also allows for quick and simple access to business critical data and by exploiting the new breed of Microsoft Power BI tools such as PowerPivot, Power View and Power Map in Excel, data model prototypes and appealing visualisations of activity data can be created.
Darren DaCosta, Head of Projects, commented "the business had reached a position where it was desirable to improve on its current reporting platform to meet the evolving needs of our customers. Ascribe have met this requirement with a flexible, scalable, industry standard BI solution which meets our current and future demands for information and our expected large growth in data volumes."
Paul Henderson, Ascribe's Business and Clinical Information Lead, commented "our work with GSTS Pathology is a strong example of our close partnership working with complex organisations to improve integration of their data; providing clarity on information throughout the business in a comprehensible BI reporting solution."
Notes to the editor:
Media contact: Claire Shuttleworth
[email protected] Tel: +44 (0)161 280 80 80
Ascribe is part of EMIS Group - the UK leader in connected healthcare software and services - and delivers software and consultancy to over 70% of the UK's NHS acute market.
Core areas of expertise for Ascribe include: hospital pharmacy and prescribing; unscheduled care (its system holds over 30 million patient records); electronic patient records (including Patient Administration Systems); and mental health systems. In addition, the company provides consultancy expertise in business intelligence, transformation and integration.
New for 2014 is the launch of a number of clinical apps. The first of these is a bed management app, which can help hospitals to improve efficiency by giving administrators and clinicians a real-time view of current occupancy rates and waiting lists.
Ascribe is a Microsoft Gold Partner and was awarded Health Partner of the Year in 2012.
© Ascribe 2014. Ascribe is a registered trademark. All other brands and product names and trademarks are the registered property of their respective companies.
About GSTS Pathology
GSTS Pathology is a unique partnership between two leading NHS Foundation Trusts, Guy's and St Thomas' and King's College and successful international service company Serco. The partnership initially went 'Live' on 1 February 2009.
We have created this business to provide pathology services that will make a real difference to patient care. We will achieve this by setting world class standards in all our activities.
UK pathology faces a period of unprecedented change. Government policy, a more demanding healthcare environment, and advances in technology, are all leading to increased demand in many areas of pathology. In the face of these challenges, GSTS Pathology aims to improve the perception of pathology's role in patient care.
GSTS Pathology combines the exceptional clinical and scientific capability of Guy's and St Thomas' and King's College Hospitals with the business and service expertise of Serco. This partnership creates an unparalleled centre of excellence, which will transform the way we provide pathology services.